Yemeni honey's journey to pharma
The article focuses on transforming Yemeni honey from a high-quality food product into a main source for the pharmaceutical industry by leveraging its distinctive biological and chemical properties. Yemeni honey, especially varieties like Sedr, Sumar, and Sal’ah, is rich in active compounds with antibacterial, anti-inflammatory, and antioxidant properties, which can be utilized in the manufacture of therapeutic and medicinal formulations. Experts emphasize the importance of developing national standard specifications, enhancing production quality, and conducting clinical studies to build a domestic pharmaceutical industry based on scientific research and partnerships between academic and industrial institutions. There is a call to shift from exporting honey as a raw material to manufacturing high-value-added products, opening new investment opportunities, contributing to national economic growth, and strengthening drug security.
Notice: This Is an AI-Generated Summary
Comments (0)